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Staphylococcal species heterogeneity in the
nasal microbiome following antibiotic
prophylaxis revealed by tuf gene deep
sequencing
Claire L. McMurray3,1*, Katherine J. Hardy2,3, Szymon T. Calus3,4, Nicholas J. Loman3 and Peter M. Hawkey2,3
Abstract
Background: Staphylococci are a major constituent of the nasal microbiome and a frequent cause of hospital-acquired
infection. Antibiotic surgical prophylaxis is administered prior to surgery to reduce a patient’s risk of postoperative
infection. The impact of surgical prophylaxis on the nasal staphylococcal microbiome is largely unknown. Here, we report
the species present in the nasal staphylococcal microbiome and the impact of surgical prophylaxis revealed by a novel
culture independent technique. Daily nasal samples from 18 hospitalised patients, six of whom received no antibiotics
and 12 of whom received antibiotic surgical prophylaxis (flucloxacillin and gentamicin or teicoplanin +/− gentamicin),
were analysed by tuf gene fragment amplicon sequencing.
Results: On admission to hospital, the species diversity of the nasal staphylococcal microbiome varied from patient to
patient ranging from 4 to 10 species. Administration of surgical prophylaxis did not substantially alter the diversity of the
staphylococcal species present in the nose; however, surgical prophylaxis did impact on the relative abundance
of the staphylococcal species present. The dominant staphylococcal species present in all patients on admission
was Staphylococcus epidermidis, and antibiotic administration resulted in an increase in species relative abundance.
Following surgical prophylaxis, a reduction in the abundance of Staphylococcus aureus was observed in carriers, but not
a complete eradication.
Conclusions: Utilising the tuf gene fragment has enabled a detailed study of the staphylococcal microbiome in the
nose and highlights that although there is no change in the heterogeneity of species present, there are changes in
abundance. The sensitivity of the methodology has revealed that the abundance of S. aureus is reduced to a low level
by surgical prophylaxis and therefore reduces the potential risk of infection following surgery but also highlights that S.
aureus does persist.
Keywords: tuf gene, Staphylococcus, S. aureus, S. epidermidis, Nose, Surgical prophylaxis, Antibiotics
Background
Staphylococci are ubiquitous commensals of the human
skin and mucous membranes and are a major cause of
hospital-acquired infections. Culture independent studies
using the 16S rRNA gene have identified staphylococci as
a major constituent of the nasal microbiome in both
healthy individuals [1, 2] and hospitalised patients [3]. The
staphylococcus genus consists of 52 species and 28 sub-
species; however, culture independent studies using the
16S rRNA gene have only been able to identify Staphylo-
coccus aureus from the staphylococcus genus, due to high
sequence similarity of the other staphylococcal species.
Other taxonomy genes including hsp60, sodA, rpoB, gap
and tuf have been shown to be more discriminative than
16S rRNA gene at identifying staphylococcus species [4].
The tuf gene encodes the elongation factor Tu protein,
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which is involved in peptide chain formation. DNA
sequencing of the tuf gene on a panel of reference strains
has shown that it can discriminate all staphylococcal spe-
cies and identification is comparable to MALDI-TOF [5].
In surgical patients, postoperative infection such as
surgical site infections (SSI) and prosthetic joint infec-
tions (PJI) cause a substantial increase in morbidity and
mortality. Staphylococci are the most common causative
agent, with 20% of SSI cases caused by S. aureus [6] and
30–43% of PJI cases caused coagulase negative staphylo-
cocci (CNS) [7]. Antibiotic surgical prophylaxis is
administered to surgical patients to reduce the risk of
postoperative infection. The only culture-dependent
study of the impact of antibiotic surgical prophylaxis on
the nasal microbiota [8] reported that antibiotics did
impact on staphylococcal diversity but that the effect
was patient specific. However, a major limitation of the
study was the culture-based methodology.
The aim of this study was to investigate the nasal
staphylococcal microbiome during antibiotic prophylaxis
using tuf gene fragment amplicon sequencing, a novel
culture independent methodology.
Methods
Study design, population, nasal sampling and swab
processing
Patients over the age of 18 years were recruited within
24 h of hospitalisation, to either one of the surgical or car-
diology wards at the Heart of England NHS Foundation
Trust via written consent. Patients were excluded if hospi-
talised for greater than 24 h or if the surgical procedure
prohibited nasal sampling pre- and/or postoperatively.
Ethical approval for the study was gained from the NRES
Committee West Midlands (08/H1206/133). On recruit-
ment, a nasal sample was taken using a flocked transport
eswab (Sterilin, UK) within 24 h of admission, and prior
to the administration of any antibiotics. Subsequently,
nasal samples were taken daily, with all the patients that
received prophylactic antibiotics receiving them after the
first and prior to the second sample being taken.
Nasal sampling was carried out by a standardised pro-
cedure, with all samples being taken by rotating the swab
three times applying a medium pressure to each nostril in
turn, and then placing in the transport medium, and
transported back to the laboratory to be processed. Swabs
were vortexed for 10 s in the 1 ml liquid Amies transport
media, 200 μl used for conventional culture and 800 μl
stored at −80 °C for tuf gene fragment amplicon
sequencing.
For all recruited patients, clinical and demographic data
was collected including age, sex, antibiotic prophylaxis
received, previous antibiotic usage and previous hospital
admission in the last 6 months.
Staphylococcal species identified by conventional culture
Staphylococci were cultured on selective media and
identified to species level as described previously [8]. In
brief, S. aureus and coagulase negative staphylococci
(CNS) isolates were preliminary identified by colony
morphology from culture media. Multiple representative
isolates of S. aureus and CNS were selected based on the
total colony count of each bacterium using the following
criteria: >50 colonies five isolates, between 10 and 50
three isolates, and <10 colonies one isolate. Isolates were
speciated by PCR and MALDI-TOF (Bruker Daltonik
GmbH, Bremen, Germany).
Tuf gene fragment amplicon sequencing
Frozen nasal samples were thawed, a 400-μl volume
added to lysing matrix B beads (MP Biomedicals UK,
Cambridge, UK) and homogenised at 6500 rpm for 30 s
using the MagNA lyser instrument (Roche Applied
Science, Penzberg, Germany). Samples were then centri-
fuged at 3000 rpm for 2 min, and the supernatants
containing DNA material stored at −20 °C.
Amplicon sequencing targeted a 412-bp staphylococcus
specific region of the tuf gene using previously published
primers [9], with the inclusion of a heterogeneity spacer,
Illumina adapter and linker [10] (see Additional file 1:
Table S1). The initial PCRs of the tuf gene fragment were
performed using the aforementioned primers in triplicate
and pooled. Subsequently, samples were cleaned up, and
an index PCR performed to add sample specific indices
and Illumina sequence adapters using the Nextera XT
index kit, as described previously [11]. DNA was quanti-
fied by Qubit 2.0 flurometer (Invitrogen, California, USA),
normalised to 0.1 ng/μl and pooled to create amplicon
library, which was quantified by qPCR using the Library
Quantification Kit for Illumina (Kapa Biosciences, Wo-
burn, MA, USA). For sequencing, PhiX Control library
(v3) (Illumina) was added to the amplicon library at 20%.
Library pool was sequenced using paired-end 300 cycles
V3 Illumina Miseq reagent kit on an Illumina Miseq
sequencer (Illumina, San Diego, CA, USA).
Illumina Miseq data processing and analysis
Initial quality filtering of raw sequence reads, construction
of contigs and subsampling of 5000 representative
sequences per sample were carried out in Mothur. Quality
filtering was carried out using strict criteria of no ambigu-
ous bases and no N bases; also, a minimum (412 bp) and
maximum (426 bp) length of contig was applied. De novo
analysis, using a 99% clustering similarity to form OTUs
and assignment of staphylococcal species using a col-
lated reference database of 37 staphylococcal species
(see Additional file 2: Table S2) [5] at 97% similarity,
was carried out in QIIME. The relative sequence
abundance of each staphylococcus species composing
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the nasal staphylococcus microbial community was
calculated for each sample. The presence of a
staphylococcal species was determined using a >0.1%
sequence abundance cut-off.
For calculation of alpha and beta diversity, de novo
analysis using a 97% clustering similarity to form OTUs,
and assignment of staphylococcal species using a
collated reference database of 37 staphylococcal species
at 97% similarity, was carried out in QIIME, and
unassigned sequences were removed. Rarefaction was
performed a depth at 1100 sequence reads.
Results
Study population
Eighteen patients were included in the study, six of which
had received no antibiotics, six who received flucloxacillin
(1 g) and gentamicin (160 mg) and six received teicoplanin
(400 mg) +/− gentamicin (160 mg) (three patients re-
ceived teicoplanin alone and three patients received teico-
planin in combination with gentamicin). No patients
received nasal decolonisation treatment (mupirocin and
chlorhedixine) prior to surgery, as all patients were MRSA
negative by routine diagnostic screening. The patient
demographic comprised of four males and 14 females,
with age ranging from 52 to 91 years (median 81 years)
(Table 1). A total of 94 swabs were taken, with a range of
3–7 days for each patient (mean = 5) (Table 1).
Tuf gene fragment amplicon sequencing
A total of 8,896,680 sequence reads were initially ana-
lysed from 94 samples, with the number of sequence
reads ranging from 1084 to 600,830 per sample (median
71,991). Following quality filtering, 72 (76.6%) samples
had >5000 sequence reads, and for these samples, 5000
representative sequence reads were subsampled; for the
remaining samples, all the sequences were analysed (see
Additional file 3: Table S3). After subsampling, 419,765
sequence reads remained to be analysed. Of the total
sequence reads, 383,471 (91.4%) were assigned a
staphylococcal species. Twenty-two staphylococcal spe-
cies were identified in total, with 14 species identified
from admission and subsequent samples and eight only
on subsequent sampling during hospitalisation. All eight
species identified from post-admission samples were
Table 1 Demographic summary of study participants
Antibiotic surgical
prophylaxis received
Antibiotic dosage Patient study
ID
Age
(years)
Sex S. aureus nasal
carriage detected
by conventional
culture on admission
Surgical
speciality
Surgical
procedure
Sample
days
No antibiotics 25 79 Female No Orthopaedic None 5
99 52 Male Yes Cardiology Angioplasty 4
101 83 Female No Cardiology Angioplasty 4
105 63 Male Yes Cardiology Angioplasty 5
111 68 Female Yes Cardiology Angioplasty 5
113 79 Female No Cardiology Angioplasty 3
Flucloxacillin
(1 g) and
gentamicin
(160 mg)
Single dose IV on induction,
and 2 further doses of
flucloxacillin (1 g) post op
at 6-h intervals
34 87 Female No Gamma Nail 7
36 87 Female No Orthopaedic Gamma Nail 7
42 88 Female Yes Orthopaedic Dynamic Hip Screw 7
51 82 Female No Orthopaedic Dynamic Hip Screw 5
56 72 Female No Orthopaedic Open Reduction of
internal fracture of
wrist and K wires
7
61 88 Male Yes Orthopaedic Total knee
replacement
5
Orthopaedic
Teicoplanin
(400 mg) +/−
gentamicin
(160 mg)
Single dose IV on induction 35b 80 Female No Orthopaedic Hemiarthroplasty 7
37b 91 Female Yes Orthopaedic Hemiarthroplasty 7
65a 76 Female No Orthopaedic Total hip
replacement
4
86b 71 Male Yes Orthopaedic Total hip
replacement
4
90a 81 Female Yes Orthopaedic Hemiarthroplasty 5
93a 89 Female Yes Orthopaedic Hemiarthroplasty 4
aTeicoplanin alone
bTeicoplanin and gentamicin
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present at <2% relative sequence abundance, with three
species <0.1% relative abundance. Staphylococcus epider-
midis (235,985, 56.2% of sequence reads) was the most
dominant species. A total of 36,294 sequence reads were
classified as unassigned. A BLAST search of unassigned
sequences showed that the majority (85%) of unassigned
sequences were from the staphylococcus genus, but
species could not be assigned as identity was below the
97% threshold. A minority (15%) of unassigned
sequences were identified as species of other Gram-
positive bacteria including Gemella haemolysans and
Abiotrophia defectiva.
Investigation of the composition of the nasal
staphylococcal microbiome in patients on admission
Fourteen staphylococcal species were identified by tuf
gene fragment amplicon sequencing in the 18 nasal sam-
ples on admission (Table 2). S. epidermidis was the dom-
inant species of the nasal staphylococcal microbiome and
was carried by 100% of patients on admission (sequence
abundance ranging from 0.74 to 94.60%). Thirteen
patients were S. aureus nasal carriers on admission with
sequence abundance ranging from 0.10 to 98.14%.
Staphylococcus capitis and Staphylococcus hominis were
present in over 75% of patients on admission, at median
relative sequence abundance of 1.49 and 0.80%,
respectively. The remaining staphylococci identified were
present at low relative sequence abundance with medians
<1.2%. The composition and diversity of the nasal
staphylococcal microbiome varied from patient to patient
on admission, with a range of 4 to 10 species present
(average 6.5 species).
On a sample by sample basis, the staphylococcal
species identified from nasal samples by conventional
culture and tuf gene fragment amplicon sequencing were
compared. In 28.3% of instances, from the 18 samples,
the same species was identified using both techniques,
with 76.5% of these at a sequence abundance of >10%
when analysed by tuf gene fragment amplicon sequen-
cing. A significant proportion (70.0%) of species were
only identified by tuf gene amplicon sequencing. Of the
species with <10% sequence abundance, only 9.0% were
also identified with conventional culture, with Staphylo-
coccus warneri detected at the lowest sequence abun-
dance (0.36%). There were only two instances of
staphylococcal species being identified by conventional
culture only (Staphylococcus lugdunensis in patient 86
and Staphylococcus haemolyticus patient 56). On admis-
sion, tuf gene fragment amplicon sequencing identified
13 patients with S. aureus carriage, compared to only 9
by conventional culture.
Impact of antibiotic surgical prophylaxis on the nasal
staphylococcal microbiome on alpha and beta species
diversity
All samples were rarefied to a depth of 1100 sequence
reads, as rarefaction curves of the Shannon index
reached a plateau at a sequencing depth of less than
1100 reads (data not shown). Ninety nasal samples were
analysed by alpha and beta diversity; four samples were
excluded due to insufficient sequence reads depth. The
alpha diversity of all 90 samples, measured by the Shan-
non index, ranged from 0.115 to 2.193 (median 1.094).
On admission and throughout hospitalisation, the alpha
diversity of nasal samples varied between individual pa-
tients irrespective of antibiotic administration. The ex-
tent of variation in alpha diversity between nasal
samples taken from an individual patient varied, with a
narrow diversity range in some patients (e.g. 1.517 to
1.917 Shannon index, patient 51) to a wide diversity
range in other patients (0.726 to 2.193 Shannon index,
patient 37). There was no significant difference in the
alpha diversity between nasal samples taken on each
sample day from patients in the three antibiotic regi-
mens. Beta diversity was measured by the Bray Curtis
dissimilarity. No substantial shift in the diversity of the
nasal staphylococcal microbiome was observed after the
administration of antibiotics when compared to admis-
sion sample (Table 3). Only one patient who received
flucloxacillin and gentamicin (patient 51) had Bray
Table 2 Frequency of Staphylococcus species identified on
admission and relative sequence abundance in study patients
(n = 18)
tuf fragment amplicon sequencing
Staphylococcal
species
Number of
patients
species was
identified in
Percentage of
patients species
was identified
in (%)
Relative
sequence
abundance
Median
(%)
Range (%)
S. aureus 13 72.2 13.00 (0.21–98.14)
S. auricularis 4 22.2 0.54 (0.44–19.16)
S. capitis 16 88.9 1.49 (0.14–22.42)
S. cohnii 5 27.8 0.98 (0.10–2.60)
S. epidermidis 18 100.0 46.86 (0.74–94.60)
S. haemolyticus 7 38.9 0.76 (0.10–3.58)
S. hominis 14 77.8 0.80 (0.24–47.86)
S. kloosii 1 5.6 0.33 (0.33–0.33)
S. lugdunensis 8 44.4 0.24 (0.10–41.46)
S. pasteuri 7 38.9 0.57 (0.12–1.04)
S. pettenkoferi 7 38.9 1.18 (0.14–4.69)
S.
saccharolyticus
4 22.2 1.05 (0.12–6.34)
S. simulans 3 16.7 0.22 (0.14–0.26)
S. warneri 11 61.1 0.53 (0.12–2.80)
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Curtis dissimilarity greater than 0.5 for all four sample
days compared to admission (0.77, 060, 0.65 and 0.78).
Impact of antibiotic surgical prophylaxis on the relative
abundance of species present in the nasal staphylococcal
microbiome
To determine the impact of antibiotic surgical prophylaxis
administration on the relative abundance of staphylococ-
cal species present in the nose, samples from days 1 and 3
were compared. In patients who received no antibiotics,
only minor changes in the relative sequence abundance of
staphylococcus species occurred, with the majority of
changes being an increase or decrease of <10% of a species
(Fig. 1). More substantial changes in relative sequence
abundance occurred in patients who received antibiotics.
An increase in the sequence abundance of S. epidermidis,
ranging from 6.7 to 47%, occurred in 10 out of 12 patients
that received antibiotics. Of the nine S. aureus nasal car-
riers that received antibiotic surgical prophylaxis, eight
had a reduced sequence abundance of S. aureus after the
administration of antibiotics ranging from 0.2 to 57.4%.
Although S. aureus relative sequence abundance was re-
duced, nasal carriage persisted. Six of the nine S. aureus
carriers identified by amplicon sequencing were also iden-
tified by conventional culture. After the administration of
antibiotics, S. aureus became undetectable by conven-
tional culture in two patients but was still detectable by
amplicon sequencing at low relative sequence abundance.
A small reduction in the sequence abundance of S. capitis,
S. haemolyticus and S. hominis was noted in the majority
of patients who received antibiotics.
Discussion
Application of a novel culture independent technique
using the tuf gene has provided a more in-depth,
detailed insight into the diversity of the nasal staphylo-
coccal microbiome, and the impact of antibiotic surgical
prophylaxis. Previous culture-dependent studies were
restricted by their limit of detection, resulting in them
being unable to reveal the true species diversity, espe-
cially at low abundance [12–14].
The novel use of the tuf gene in this culture independ-
ent study, as opposed to the more widely used 16S rRNA
gene, has enabled the study of the nasal staphylococcal
microbiome at species level [1–3, 12, 15–22]. Studies uti-
lising the 16S rRNA gene have been unable to identify
staphylococci at species level due to the high gene
sequence similarity of 16S rRNA gene between staphylo-
coccal species and thus described staphylococci either as
Firmicutes staphylococcus genus, only identifying S.
Table 3 The beta diversity of the nasal staphylococcal microbiome between admission and other sample days after administration
of antibiotic surgical prophylaxis in individual study patients, measured by the Bray Curtis dissimilarity distance
Antibiotic surgical prophylaxis received Patient study
ID
Beta diversity (Bray Curtis dissimilarity)
Sample day
2 3 4 5 6 7
No antibiotics 25 0.24 0.42 # 0.29
99 0.12 0.04 0.09
101 0.55 0.35 0.54
105 0.01 0.09 0.02 0.37
111 0.53 0.09 0.06 0.35
113 0.06 0.20
Flucloxacillin (1 g) and gentamicin (160 mg) 34 0.23 0.21 0.20 0.20 0.21 #
36 0.35 0.10 0.11 0.13 0.14 0.41
42 0.25 0.19 0.66 0.33 0.70 0.54
51 0.42 0.25 0.34
56 0.03 0.11 0.07 0.26 # 0.17
61 0.77 0.60 0.65 0.78
Teicoplanin (400 mg) +/− gentamicin (160 mg) 35b 0.21 0.33 0.33 0.24 # 0.17
37b 0.30 0.06 0.22 0.32 0.40 0.20
65a 0.08 0.08 0.06
86b 0.10 0.18 0.23
90a 0.06 0.08 0.05 0.36
93a 0.36 0.49 0.29
aTeicoplanin alone
bTeicoplanin and gentamicin
#Beta diversity was not calculated for sample as excluded due to insufficient read depth (<1100)
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aureus to species level. Kaspar et al. [12] recently demon-
strated this limitation, with only S. aureus being identified
by both 16S rRNA and culture, with nine other staphylo-
coccus species including S. epidermidis and S. captis only
being identified to species level by culture.
The use and type of antibiotic agents used for surgical
prophylaxis has changed over the last 20 years due to the
increase in antibiotic resistance and changing practices.
Most guidance on surgical prophylaxis now recommends
the use of either a single dose of antibiotics or continuation
for less than 24 h [23]. However, there are no studies that
have used culture independent methods to investigate the
impact of surgical prophylaxis on the human microbiome.
A recent study looking at longer courses of antibiotics (5–
10 days) on the salivary and faecal microbiome found very
similar results to the current study in the salivary micro-
biome with it remaining relatively stable following antibi-
otics, whilst large changes were observed in the faecal
microbiome [24]. The authors hypothesised that these
differences may be due either to the pharmacokinetics of
the antibiotics, or possibly that the populations in the saliv-
ary microbiome are more intrinsically resilient. Whilst the
nasal microbiome is different to that of the salivary micro-
biome, it is still exposed to some of the same stresses such
as changes in temperature, oxygen and physical disturbance
and may mean that these populations are intrinsically more
resilient.
The most significant change in the nasal staphylococcal
microbiome after the administration of antibiotics was the
increase in abundance of S. epidermidis, and the reduction
Fig. 1 Relative sequence abundance of nasal staphylococcal microbiome on day 1 and day 3 of 18 patients who received antibiotic surgical prophylaxis
regimen: a no antibiotics, b flucloxacillin and gentamicin, and c teicoplanin +/− gentamicin. Colours indicate S. aureus (red), S. epidermidis (green), S. capitis
(blue), S. hominis (purple), S. haemolyticus (yellow), other staphylococci (orange), unassigned sequences (white). Number.number designation on x-axis
represents the patient ID and sample day, with day 1 being pre-antibiotic treatment and day 3 being post-antibiotic treatment. Teicoplanin alone (patient
study IDs 65, 90 and 93), teicoplanin and gentamicin (patient study IDs 35, 37 and 86)
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but not eradication of S. aureus in nasal carriers. Within
this study population of orthopaedic patients undergoing
surgery involving implants, both these findings are clinic-
ally significant. In orthopaedic surgery, nasal carriage of S.
aureus has been identified as the most important risk fac-
tor of developing SSI, with a relative risk of 8.9 [25].
Staphylococci are the leading cause of PJI with CNS caus-
ing 30–43% of infections, predominantly S. epidermidis,
and S. aureus causing 12–23% [7]. Although PJIs occur in
<1% of operations, the infections are difficult to treat
involving additional surgery and prolonged antibiotic
therapy, with a high morbidity. Other staphylococcal
species present in the nose, for example S. capitis and S.
lugdunensis, although less pathogenic than S. aureus and
S. epidermidis, have been reported to cause PJI [26, 27],
and infective endocarditis [28, 29].
Molecular methods for screening of S. aureus nasal car-
riage have been demonstrated to have a higher sensitivity
than culture [30, 31]. Data from this study supports these
findings, with only nine patients being identified as nasal
carriers by culture as opposed to 13 by sequencing on ad-
mission. Due to the increased sensitivity of molecular
methods, questions have been raised about false positives
compared to culture methods; however, as this study is
able to look at S. aureus relative abundance, it is able to
provide evidence to demonstrate that it is not due to false
positives.
S. aureus nasal carriage relative abundance was reduced
to a low level by antibiotic surgical prophylaxis, which
might be associated with a reduced risk of SSI, but it was
not eradiated. Our finding may explain the higher S. aur-
eus SSI rate, observed by Bode and colleagues, in patients
who received surgical prophylaxis alone (8.4%), compared
to patients who received prophylaxis in combination with
S. aureus decolonisation with mupirocin and chlorhexi-
dine prior to surgery (3.6%) [32].
This is the first culture independent study to use an
alternative taxonomy gene to study the nasal staphylo-
coccal microbiome in detail during surgical prophylaxis.
The main limitation of the study is the small patient
population analysed and its demographic bias of female
patients; further investigation is required to determine
the significance of these changes.
Conclusions
Tuf gene fragment amplicon sequencing has enabled a de-
tailed culture independent study of the impact of surgical
prophylaxis on the nasal staphylococcal microbiome during
surgical prophylaxis. As the new technique discriminates to
staphylococcus species level, it could be used to study
staphylococci rich microbial communities and expand our
knowledge of staphylococcal diversity and the potential risk
of infection in at risk patient groups.
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